Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article

Journal of Neurosurgery

Volumn 117, Issue 6, 2012, Pages 1032-1038

  Bloch, Orin ^a   Han, Seunggu J ^a   Cha, Soonmee ^a   Sun, Matthew Z ^a   Aghi, Manish K ^a   Mcdermott, Michael W ^a   Berger, Mitchel S ^a   Parsa, Andrew T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Craniotomy; Extent of resection; Glioblastoma; Oncology; Survival

Indexed keywords

BEVACIZUMAB; ERLOTINIB; IRINOTECAN; LOMUSTINE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CRANIOTOMY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; GLIOBLASTOMA; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; SAN FRANCISCO; TREATMENT OUTCOME;

EID: 84870875769     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.9.JNS12504     Document Type: Article

References (19)

1. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, et al: Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227-1233, 2005 (Pubitemid 40328094)
2. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993 (Pubitemid 23133591)
3. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20(4):E1, 2006
4. Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M: Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103:611-618, 2011
5. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H: Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol 12:1062-1070, 2011
6. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001 (Pubitemid 32799739)
7. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003 (Pubitemid 37040405)
8. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009
9. Pichlmeier U, Bink A, Schackert G, Stummer W: Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025-1034, 2008
10. Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-764, 2008
11. Sanai N, Berger MS: Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics 6:478-486, 2009
12. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. Clinical article. J Neurosurg 115:3-8, 2011
13. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:51-55, 1998 (Pubitemid 28027566)
14. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V: Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997-1003, 2011
15. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al: Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338-1345, 2008
16. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
17. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al: Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564-576, 2008
18. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
19. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR: Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40:151-160, 1998 (Pubitemid 29010168)